{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:19:53Z","timestamp":1787721593650,"version":"build-2784847793"},"reference-count":21,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023554","name":"Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias","doi-asserted-by":"crossref","award":["OA23\/014"],"award-info":[{"award-number":["OA23\/014"]}],"id":[{"id":"10.13039\/501100023554","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Background: Olfactory dysfunction (OD) is a key symptom of chronic rhinosinusitis with nasal polyps (CRSwNP). Dupilumab improves clinical outcomes, including patient-reported olfactory function. This study aimed to analyze correlations between patient-reported olfactory improvement, quality of life, and endoscopic outcomes in patients treated with dupilumab. Methods: A real-life, single-center retrospective study included 35 patients with severe, uncontrolled CRSwNP treated with dupilumab. Patient-reported olfactory function was assessed using a visual analog scale (VAS-olfaction), quality of life with the Sinonasal Outcome Test-22 (SNOT-22), and polyp size with the Nasal Polyp Score (NPS) at baseline, 6 months, and 12 months. Changes from baseline were analyzed using the Wilcoxon signed-rank test, whereas correlations were evaluated using Spearman\u2019s rank correlation coefficient. Results: Dupilumab was associated with significant improvements in patient-reported olfactory function, quality of life, and polyp size at 6 and 12 months. Improvements in VAS-olfaction correlated significantly with SNOT-22 at 6 months (p = 0.035) and 12 months (p = 0.024). In a sensitivity analysis excluding the smell\/taste item from the SNOT-22, these correlations were attenuated and no longer reached statistical significance. No significant correlation was observed between patient-reported olfactory improvement and NPS. Conclusions: Patient-reported olfactory improvement correlated with quality of life but not with reductions in global polyp burden. These findings suggest that this improvement may not be fully explained by changes in polyp size alone.<\/jats:p>","DOI":"10.3390\/medicines13030026","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:49:34Z","timestamp":1787582974000},"page":"26","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does Patient-Reported Olfactory Improvement Correlate with Quality of Life and Polyp Size Reduction in Patients with CRSwNP Treated with Dupilumab?"],"prefix":"10.3390","volume":"13","author":[{"given":"Brian","family":"Hern\u00e1ndez-Mart\u00edn","sequence":"first","affiliation":[{"name":"Departamento de Otorrinolaringolog\u00eda, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35010 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam del Carmen","family":"Marrero-Ramos","sequence":"additional","affiliation":[{"name":"Departamento de Otorrinolaringolog\u00eda, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35010 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Soledad","family":"Cabrera-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Departamento de Otorrinolaringolog\u00eda, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35010 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-8062","authenticated-orcid":false,"given":"Jes\u00fas Javier","family":"Ben\u00edtez-Rosario","sequence":"additional","affiliation":[{"name":"Departamento de Otorrinolaringolog\u00eda, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35010 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4608-1040","authenticated-orcid":false,"given":"Carmen Delia","family":"D\u00e1vila-Quintana","sequence":"additional","affiliation":[{"name":"Departamento de M\u00e9todos Cuantitativos en Econom\u00eda y Gesti\u00f3n, Universidad de Las Palmas de Gran Canaria, 35017 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9445-4537","authenticated-orcid":false,"given":"Mar\u00eda Sandra","family":"Dom\u00ednguez-Sosa","sequence":"additional","affiliation":[{"name":"Departamento de Otorrinolaringolog\u00eda, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, 35010 Las Palmas de Gran Canaria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J. Asthma Allergy"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Stilo, G., Messina, G., Lo Faro, C., Ruta, S., Frangipane, S., Mariut, D., Giunta, G., Distefano, M.E., Zappal\u00e0, A.G., and Maniaci, A. (2025). Correlation Between Smell Recovery and Nasal Polyp Score in Patients Treated with Dupilumab: A Real-Life Retrospective, Observational, Monocentric Study. J. Pers. Med., 15.","DOI":"10.3390\/jpm15050164"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/DDDT.S243053","article-title":"Dupilumab: Clinical Efficacy of Blocking IL-4\/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps","volume":"14","author":"Kariyawasam","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Allinne","year":"2020","journal-title":"Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): Results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/all.15772","article-title":"Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL)","volume":"78","author":"Pasquini","year":"2023","journal-title":"Allergy"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/all.15134","article-title":"Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"77","author":"Lans","year":"2022","journal-title":"Allergy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1007\/s00405-025-09540-4","article-title":"Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric real-life study","volume":"282","author":"Marco","year":"2025","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2411018","DOI":"10.1080\/07853890.2024.2411018","article-title":"Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients","volume":"56","year":"2024","journal-title":"Ann. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11882-025-01192-y","article-title":"Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis","volume":"25","author":"Alobid","year":"2025","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.18176\/jiaci.0939","article-title":"Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review","volume":"33","author":"Barroso","year":"2023","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cantone, E., De Corso, E., Ricciardiello, F., Di Nola, C., Grimaldi, G., Allocca, V., and Motta, G. (2022). Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081215"},{"key":"ref_14","unstructured":"Reddel, H.K., Bacharier, L.B., Bateman, E.D., Brightling, C.E., Brusselle, G.G., Buhl, R., Cruz, A.A., Duijts, L., Drazen, J.M., and FitzGerald, J.M. (2021, October 19). Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Available online: http:\/\/www.ginasthma.org."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1398-9995.2011.02728.x","article-title":"Practical guide to skin prick tests in allergy to aeroallergens","volume":"67","author":"Bousquet","year":"2012","journal-title":"Allergy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/all.15650","article-title":"European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis","volume":"78","author":"Gevaert","year":"2023","journal-title":"Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaip.2020.10.036","article-title":"The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice","volume":"9","author":"Desai","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/all.70032","article-title":"Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage","volume":"81","author":"Montuori","year":"2026","journal-title":"Allergy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/19458924231153485","article-title":"Olfaction Now and in the Future in CRSwNP","volume":"37","author":"Qureshi","year":"2023","journal-title":"Am. J. Rhinol. Allergy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/alr.21994","article-title":"Role of tissue eosinophils in chronic rhinosinusitis\u2013associated olfactory loss","volume":"7","author":"Hauser","year":"2017","journal-title":"Int. Forum Allergy Rhinol."}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/13\/3\/26\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:23:17Z","timestamp":1787718197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/13\/3\/26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medicines13030026"],"URL":"https:\/\/doi.org\/10.3390\/medicines13030026","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}